As of May 26
| -0.90 / -5.91%|
The 5 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 29.00, with a high estimate of 32.00 and a low estimate of 18.00. The median estimate represents a +102.23% increase from the last price of 14.34.
The current consensus among 5 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.